CellaVision and Sysmex enhance partnership by signing a global distribution agreement
CellaVision extends and broadens cooperation with Sysmex by entering a global distribution agreement. The agreement gives Sysmex a non-exclusive right to sell CellaVision's products in hematology laboratories worldwide.
"We extend our successful collaboration with Sysmex and enhance the agreement to comprise more markets, including Japan, the country of origin for Sysmex Corporation", says Yvonne Mårtensson, CEO of CellaVision. "Sysmex has the global leadership position within hematology, and we are extremely pleased that they continue to promote and sell our analyzers to their customers, providing us with a very strong sales channel and the ability to carry on our market penetration. Sysmex is the perfect partner and strategic match in our commitment to strengthen our position as world leader within digital morphology analysis to hematology laboratories."
Sysmex and CellaVision have been developing their partnership since 2001, when they partnered in the European market. Starting April 1, 2010, the non-exclusive agreement comprises all international markets but Canada. CellaVision continues to sell direct through its own sales organizations in the Nordic countries, the US, Canada and Japan. In 2009, Europe accounted for 41% of sales, North America for 55% and the rest of the world for 4%.
Other news from the department business & finance
